Skip to main content
. 2012 Aug 29;10:97. doi: 10.1186/1741-7015-10-97

Table 1.

Clinical characteristics of intracranial hemorrhage among patients of different types of hematological malignancies

Number of patients

Subtype AML (n = 43) APL (n = 9) ALL (n = 5) Lymphoma (n = 7) Myeloma (n = 8) P value
Age: 0.094
≥60 years 19 2 1 6 4
<60 years 24 7 4 1 4
Gender: 0.461
Male 32 5 2 4 5
Female 11 4 3 3 3
Underlying hypertension: 0.428
Yes 12 3 0 3 1
No 31 6 5 4 7
Diabetes mellitus: 0.274
Yes 3 1 0 2 0
No 40 8 5 5 8
Sepsis: 0.096
Yes 16 5 5 4 4
No 27 4 0 3 4
Post HSCT: 0.347
Yes 8 0 0 0 1
No 35 9 5 7 7
Disease status: 0.409
Remission 6 2 0 0 0
Active 37 7 5 7 8
CNS involvement: <0.001
Yes 0 0 0 5 1
No 43 9 5 2 7
Leukocyte count: 0.642
≥100,000 cells/μl 9 2 0 1 0
<100,000 cells/μl 34 7 5 6 8
Platelet count: 0.560
≥20,000 cells/μl 27 6 3 6 4
<20,000 cells/μl 16 3 2 1 4
Prothrombin time: 0.493
INR ≥1.5 10 2 1 1 1
INR <1.5 32 7 4 6 7
Location:
Cerebral cortex 37 7 5 4 5 0.326
Basal ganglia 9 1 1 1 1 0.941
Brainstem 4 0 0 1 0 0.628
Cerebellum 4 2 0 1 3 0.213
Multiple 20 5 0 3 5 0.240
Type:
Intraparenchymal hemorrhage 35 7 5 4 5 0.336
Subarachnoid hemorrhage 8 2 2 0 3 0.349
Subdural hemorrhage 11 2 1 4 4 0.307
Epidural hemorrhage 1 0 0 0 2 0.041
Intraventricular hemorrhage 10 4 1 3 2 0.618

ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; APL = acute promyelocytic leukemia; CNS = central nervous system; HSCT = hematopoietic stem cell transplantation; INR = international normalized ratio.